CNS/Brain Cancer
Conference Coverage
Data emerging to support personalized nutrition in oncology
SAN DIEGO – Fasting has been linked to improvements in chemotherapy efficacy and decreased side effects.
From the Journals
Global project reveals cancer’s genomic playbook
The Pan-Cancer Analysis of Whole Genomes, an international collaboration, reveals the complexity of oncogenesis.
From the Journals
QoL good for MGMT-methylated glioblastoma patients with lomustine-temozolide
Adding lomustine to temozolomide did not decrease quality of life for patients, apart from clinically insignificant differences in mental function...
From the Journals
IORT boosts local control, survival of glioblastoma
A single application of intraoperative radiotherapy followed by standard chemotherapy and maintenance improved outcomes vs. those of historical...
From the Journals
HER2-mutant NSCLC confers high brain metastases risk
Patients with HER2-mutated non–small cell lung cancer were more likely to develop brain metastases on therapy than patients with KRAS mutations....
From the Journals
Drug-inducible gene therapy unlocks IL-12 for glioblastoma
In 31 patients who had their tumors excised, intraoperative site injection with an IL-12 vector, followed by postoperative administration of...
From the Journals
Investigators target brain metastases in NSCLC
In a retrospective study of matched primary and metastases samples, PI3K signaling was associated with an increased risk of brain metastases, and...
News
FDA approves bevacizumab-bvzr for several cancers
The bevacizumab biosimilar is now approved for metastatic colorectal cancer, advanced non-squamous non–small cell lung cancer, recurrent...
From the Journals
EHR default order slashes unnecessary imaging during palliative RT
After implementation of the default order specifying no daily imaging during palliative radiation therapy, patients were 63% less likely to...
Conference Coverage
Trial matches pediatric cancer patients to targeted therapies
Nearly a quarter of the patients screened as part of the National Cancer Institute–Children’s Oncology Group Pediatric MATCH trial have been...
Conference Coverage
Entrectinib exhibits activity in children with solid tumors
Entrectinib produced responses in patients who had fusions or mutations in target genes.